Trainee Publications

  • Wei, J, Schottenfeld, D, Cooper, K, Taylor, JMG, Faerber, G, Velarde, M, Bree, R, Montie, J, Cooney, K: “The Natural History of Lower Urinary Tract Symptoms Among African-American Men: Relationships with Aging, Prostate Size, Flow Rate and Bother.” J Urol, 165:1521-25, 2001.
  • Taylor, JMG, Cooper, K, Wei, J, Sarma, A, Raghunathan, T, Heeringa, S: “Use of Multiple Imputation to Correct for Nonresponse Bias in a Survey of Urologic Symptoms among African-American Men”. Am J Epidemiol, 156: (8) 774-782, 2002.
  • Taub, DA, Hollenbeck, BK, Cooper, KL, Dunn, RL, Miller, DC, Taylor, JMG, Wei, JT: “Racial Disparities in Resource Utilization for Cystectomy.” Urology, 67(2): 288-93, 2006.
  • Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Schuchert M, Cooper K, Land SR, Belani CP: “Long-Term Results of a Phase II Trial of Neoadjuvant Chemotherapy Followed by Esophagectomy for Locally Advanced Esophageal Neoplasm,” Annals of Thoracic Surgery 85: 1930-1937, 2008.
  • Yildiz-Aktas IZ, Dabbs DJ, Cooper KL, Chivukula, M, McManus K, Bhargava, R: "The Effect of 96-Hour Formalin Fixation on the Immunohistochemical Evaluation of Estrogen Receptor, Progesterone Receptor, and HER2 Expression in Invasive Breast Carcinoma" Am J Clin Pathol (Accepted)
  • Jankowitz RC, Cooper KL, Erlander MG, Ma XJ, Kesty NC, Li H, Chivukula M, Brufsky A, “Prognostic utility of the breast cancer index and comparison to Adjuvant.” Online in a clinical case series of early breast cancer. Breast Cancer Research 13:R98, 2011

  • Dawson, LA, Biersack, MP, Schipper, MJ, Ten Haken, RT: “A novel approach to evaluate partial volume-dose-complication relationships.”- ABSTRACT. Int J Radiat Oncol Biol Phys, 54: (2), Supplement 1, 127-128, 2002.
  • Miller, C, Lin, L, Moy, J, Schipper, M, Normolle, D, Brenner, D, Iannettoni, M, Orringer, M, Beer, D: “Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade Dysplasia.” Clin Cancer Res, 9: 4819-4825, 2003.
  • Dawson, LA, Saito, NG, Ratanatharathorn, V, Uberti, JP, Adams, PT, Ayash, LJ, Reynolds, CM, Silver, SM, Schipper, MJ, Lichter, AS, Eisbruch, A: “Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.” Int J Radiat Oncol Biol Phys, 59(1), 208-218, 2004.
  • Eisbruch, A, Marsh, L, Dawson, L, Bradford, C, Teknos, T, Chepeha, D, Worden, F, Urba, S, Lin, A, Schipper, M, Wolf, G: “Recurrences near base of Skull After IMRT of Head and Neck Cancer: Implications for Target Delineation in High Neck and for Parotid Sparing.” Int J Rad Onc Biol Phys, 59: 28-42, 2004.
  • Krueger E, Schipper M, Koelling T, Marsh R, Butler J, Pierce L: “Cardiac Chamber and Coronary Artery Doses Associated with Postmastectomy Radiotherapy Techniques to the Chest Wall and Regional Nodes.” Int J Radiat Oncol Biol Phys, 60(4): 1195-203, 2004.
  • Suh W, Schott A, Hayman J, Schipper M, Shewach D, Pierce L: “A phase I Dose Escalation Trial of Gemcitabine with Radiotherapy for Breast Cancer in the Treatment of Unresectable Chest Wall Recurrences.” Breast J, 10: 204-210, 2004.
  • Feng M, Jabbari S, Lin A, Bradford C, Chepeha D, Teknos T, Worden F, Tsien C, Schipper M, Wolf G, Dawson L, Eisbruch A: “Predictive factors of local-regional recurrences following IMRT for head and neck cancer.” ABSTRACT, Intl J Radiat Oncol Biol Phys, 60: S506-S507, 2004.
  • Feng M, Jabbari S, Lin A, Bradford CR, Chepeha DB, Teknos TN, Worden FP, Tsien C, Schipper MJ, Wolf GT, Dawson LA and Eisbruch A: “Predictive factors for loco-regional (LR) failures after intensity modulated radiotherapy (IMRT) for head and neck (HN) cancers.” Radiotherapy and Oncology 2005; 77: 32-8.
  • Hayman, JA, Kabeto, MU, Schipper, MJ, Bennett, JE, Vicini, FA, Pierce, LJ: “Assessing the Benefit of Radiation Therapy After Breast-Conserving Surgery for Ductal Carcinoma-In-Situ.” J Clin Oncol, 23: (22), 5171-5177, 2005.
  • Kong, FM, Ten Haken, RK, Schipper, MJ, Sullivan, MA, Chen, M, Lopez, C, Kalemkerian, GP, Hayman, JA: “High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study.” Int J Radiat Oncol Biol Phys, 63: (2), 324-33, 2005.
  • Lin, A, Jabbari, S, Worden, FP, Bradford, CR, Chepeha, DB, Teknos, TN, Liao, JJ, Nyquist, G, Tsien, C,  Schipper, MJ, Urba, S, Wolf, GT, Eisbruch, A: “Metabolic abnormalities associated with weight loss during chemo-irradiation of head and neck cancer.” Int J Radiat Oncol Biol Phys, 63(5):1413-18, 2005.
  • Khan, MK, Mamou, F, Schipper, MJ, Kwitney, A, Warnat, A, Nair, B, Kariapper, MS, Brewer, G, Normolle, D, Merajver, S, Teknos, T: “The combination of Tetrathiomolybdate (TM) and radiation therapy in an in vivo mouse tumor model of head and neck squamous cell carcinoma (HNSCC).” Arch Otolaryngol Head Neck Surg, 132(3): 333-8, 2006.
  • Mamou, F., May, K., Schipper, M., Gill, N., Kariapper, M., Nair, B., Brewer, G., Normolle, D., Khan, M. “Tetrathiomolybdate Blocks bFGF- but not VEGF- induced Incipient Angiogenesis.“ In Vitro, Anticancer Research 26: 1753-1758, 2006.
  • Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C and Eisbruch A. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiation Oncology Biology Physics 66(2): 445-53, 2006.
  • Schipper, MJ, Taylor, JMG, Lin, X: “Bayesian Generalized Monotonic Functional Mixed Models for the Effects of Radiation Dose Histograms on Normal Tissue Complications.” Statistics in Medicine, 26(25) 4643-56, 2007.
  • Nandalur KR, Hardie AD, Raghavan P, Schipper MJ, Baskurt E, Kramer CM. Composition of the Stable Carotid Plaque: Insights from a Multidetector computed tomography study of plaque volume. Stroke ,38(3):935-40, 2007.
  • Dillman JR, Caoili EM, Cohan RH, Ellis JH, Francis IR and Schipper MJ. Detection of upper tract urothelial neoplasms: Sensitivity of axial, coronal reformatted, and curved-planar reformatted image-types utilizing 16-row multi-detector CT urography. Abdominal Imaging, 33(6):707-16, 2008.
  • Khan MK, Minc LD, Nigavekar SS, Kariapper MST, Nair BM, Schipper MJ, Cook AC, Lesniak WG and Balogh LP. Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy. Nanomedicine: Nanotechnology, Biology, and Medicine , 4(1): 57-69, 2008
  • Sundaram B, Gross BH, Martinez FJ, Oh E, Müller NL, Schipper M, Kazerooni EA: “Accuracy of High-Resolution CT in the Diagnosis of Diffuse Lung Disease: Effect of Predominance and Distribution of Findings.” Am. J. Roentgenol., 191: 1032–1039, 2008
  • Soto DE, Glaser S, Roberts RH, Schipper MJ, McLaughlin PW, Ray ME, SandlerHM, Pan CC (2008). Impact of common iliac nodal treatment on radiation outcomes in localized prostate cancer. Urology 71; 313-317.
  • Quint LE, Cheng J, Schipper MJ, Chang A, Kalemkerian G: “Lung Lesion Doubling Times: Values and Variability Based on Method of Volume Determination.” J Clin Radiol, 63(1): 41-8, 2008.
  • Rufener SL, Patel S, Kazerooni EA, Schipper MJ and Kelly AM. Comparison of on-callradiology resident and faculty interpretation of 4 and 16-row multidetector CT pulmonary angiography with indirect CT venography. Academic Radiology , 15(1) 71-6, 2008.
  • Schipper, MJ, Taylor, JMG, Lin, X: “Generalized Monotonic Functional Mixed Models with Application to Modeling Normal Tissue Complications.” Applied Statistics, 57(2), 149-163, 2008
  • Sisson JC, Schipper MJ, Nelson CC, Freitas JE and Frueh BR. Radioiodine therapy and Graves’ Eye Disease. Journal of Nuclear Medicine 2008; 49(6): 923-30.
  • Agarwal P, Patel S, Corbett J, Jung JI, Barber K, Schipper MJ, and Kazerooni EA (2009). Left ventricular functional analysis with 16 and 64-row multidetector CT: comparison with gated SPECT. Journal of Computer Assisted Tomography 33(1): 8-14.
  • Goodsitt MM, Chan HP, Way TW, Schipper MJ, Larson SC and Christodoulou EG (2009) Quantitative CT of lung nodules: dependence of calibration on patient body size, lung size and calibration nodule size for single- and dual-energy techniques. Medical Physics, 36(7): 3107-3121.
  • Sheikh K, Schipper MJ and Hoeffner EG (2009) Feasibility of superficial temporal artery as input artery in cerebral CT perfusion. American Journal of Roentgenology, 192(6):W321-9.
  • Sundaram B, Miller C, Schipper MJ, Cohan RH and Francis IR (2009) Can CT features diagnose surgical adult bowel intussusceptions? American Journal of Roentgenology, 193(2): 471-8.
  • Pabon-Ramos W, Caoili E, Cohan R, Stephens T, Francis I, Ellis J, Korobkin M and Schipper M. Excretory urography: trends in clinical use and diagnostic yield. Abdominal Imaging. 2009 Jun 27. [Epub ahead of print]
  • Caoili EM, Cohan RH, Ellis JH, Dillman J, Schipper MJ, Francis IR (2009) Medical decision making regarding computed tomographic radiation dose and associated risk: the patient's perspective. Arch Intern Med, 169(11):1069-71.
  • Chen NG, Fowlkes JB, Carson PL, Schipper MJ and LeCarpentier GL. Rapid 3D imaging of contrast flow: Application to perfused kidney vasculature. Ultrasound in Medicine & Biology 2009; 35(5):813-28.
  • Ash L, Schipper MJ and Mukherji SK. The Utricular Macula: qualitative and quantitative analysis using 3T imaging. Journal of Computer Assisted Tomography 2010 Jan;34(1):93-7.
  • Deiterle F, Sistare F, Goodsaid F, Schipper MJ, Mattes W: (2010) “Renal Biomarker Qualification Submission: A dialog between the FDA/EMEA and PSTC.” Nature Biotechnology, 28(5): 455-62.
  • Sistare F, Goodsaid F, Schipper MJ, Yu Y (2010) Towards establishing good biomarker qualification practices for new kidney safety biomarkers in early drug development and regulatory decision-making. Nature Biotechnology, 28(5): 446-54.
  • Pai D, Willat JM, Korobkin M, Cohan RH, Ellis JH, Francis IR, Wolf JS and Schipper MJ (2010) CT appearances following laparoscopic partial nephrectomy for renal cell carcinoma using a rolled cellulose bolster.” Cancer Imaging, 2010, 10:161-8.
  • Dewaraja YK, Schipper MJ, Roberson PL, Wilderman SJ, Regan D, Amro H, Koral KF, Kaminski MS and Avram AM (2010) Dosimetry of I-131 tositumomab radioimmunotherapy: tumor dose-response using measures from 3-dimensional calculation including radiobiologic modeling. Journal of Nuclear Medicine, 51(7): 1155-62.
  • Roberson PL, Amro H, Wilderman SJ, Avram AM, Kaminski MS, Schipper MJ and Dewaraja YK. Using an Equivalent Uniform Dose Model to Categorize Response to Therapy for Patients with Non-Hodgkin’s Lymphoma. Medical Physics. (Accepted).
  • Holder, D and Schipper, MJ. Statistical issues in biomarker research. In: Biomarkers in Medicine, Drug Discovery and Environmental Health, edited by Vishal Vaidya and Joseph Bonventre, John Wiley and Sons, New York, Chapter 24; 2010.
  • Tsien CI, Brown D, Normolle D, Schipper M, Morand P, Junck L, Heth JA, Gomez-Hassan D, Ten-Haken R, Chenevert TL, Cao Y, Lawrence TS: "Concurrent Temozolomide and Dose-Escalated Intensity Modulated Radiation Therapy in Newly Diagnosed Glioblastoma." Clin Cancer Res. 2011 Nov 7. Epub ahead of print PMID:22065084
  • Little M, Schipper M, Feng FY, Vineberg K, Cornwall C, Murdoch-Kinch CA, Eisbruch A: "Reducing Xerostomia After Chemo-IMRT for Head-and-Neck Cancer: Beyond Sparing the Parotid Glands." Int J Radiat Oncol Biol Phys. 2011 Nov 4. Epub ahead of print PMID:22056067
  • Halverson S, Schipper M, Blas K, Lee V, Sabolch A, Olson K, Sandler HM, Feng FY, Hamstra DA : "The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: Evaluation and optimization in patients at higher risk of relapse." Radiother Oncol. 2011 Dec;101(3):513-20. Epub 2011 Jun 22. PMID:21703711 PubMed - in process
  • Roberson PL, Amro H, Wilderman SJ, Avram AM, Kaminski MS, Schipper MJ, Dewaraja YK: "Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphoma." Eur J Nucl Med Mol Imaging. 2011 May;38(5):874-83. Epub 2010 Dec 21. PMID:21174088
  • Schipper MJ, Koral KF, Avram AM, Kaminski MS, Dewaraja YK: “Prediction of therapy tumor absorbed dose estimates in I-131 radioimmunotherapy using tracer data via a mixed model fit to time-activity.” Cancer Biotherapy & Radiopharmaceuticals, (accepted)

  • Cooper GS, Johnson CC, Lamerato L, Poisson LM, Schultz L, Simpkins J, Wells K, Yood MU, Chase G, Nathanson SD, Lafta JE: “Use of Guideline Recommended Follow-Up Care in Cancer Survivors: Routine or Diagnostic Indications?” Medical Care, 44: 590-594, 2006.
  • Lafata JE, Simpkins J, Lamerato L, Poisson L, Divine G, Johnson CC. The economic impact of false-positive cancer screens.Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2126-32.
  • Poisson LM, Ghosh D: “Statistical issues and analyses of in vitro and in vivo genomic data in order to identify clinically relevant profiles.” Cancer Informatics, 1: 231-243, 2007. PMCID: PMC2600568
  • Ghosh, D, Poisson LM (2009) "Omics" data and levels of evidence for biomarker discovery.” Genomics, 93:13-16
  • Patwa TH, Li C, Poisson LM, Kim HY, Pal M, Ghosh D, Simeone DM, Lubman DM (2009) The Identification of Phosphoglycerate kinase-1 (PGK-1) and Histone H4 Auto-Antibodies in Pancreatic Cancer Patient Serum Using a Natural Protein Microarray. Electrophoresis. Jun;30(12):2215-26. PMID: 19582723
  • Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM (2010) Response to: Jentzmik, F. et al. Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumors.” Eur urol 2010;58:12-8., European urology 2010;58(3):e29-30.
  • Khan AP, Poisson LM, Bhat V, Fermin D, Zhao R, Nesvizhskii AI, Omenn GS, Chinnaiyan AM, Sreekumar A: (2010) “Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer.” Molecular and Cellular Proteomics, 9: 298-312, PMID: 19955085
  • Sreekumar A, Poisson LM, Cao Q, Rajendiran TM, Varambally S, Lonigro RJ, Li Y, Cao X,
  • Nyati MK, Kalyana-Sundaram S, Mehra R, Ahsan A, Vellaichamy A, Byun J, Han B, Omenn GS,
  • Ghosh D, Wei JT, Pennathur S, Berger A, Beecher C, Chinnaiyan AM (2009) “Metabolomic Profiling of Prostate Cancer Progression.” Nature, 475:910-14
  • Poisson LM, Taylor JMG, Ghosh D: “Integrative set enrichment testing for multiple omics platforms.” BMC Bioinformatics 2011, 12:459
  • Jain R, Poisson L, Narang J, Scarpace L, Rosenblum ML, Rempel S, Mikkelsen T, "Correlation of Perfusion Parameters with Genes Related to Angiogenesis Regulation in Glioblastoma: A Feasibility Study" Am J Euroradiology (accepted)

  • Deng H, Zwetchkenbaum S, Noone A. "Bond strength of silicone to polyurethane following immersion of silicone in cleaning solutions." J Prosthetic Dentistry, 91(6): 582-5, 2004.
  • Kroon HM, Li Q, Teitz-Tennenbaum S, Whitfield JR, Noone AM, Chang AE: “4-1BB Co-stimulation of Effector T Cells for Adoptive Immunotherapy of Cancer: Involvement of Bcl Gene Family Members. Journal of Immunotherapy, 30; 406-16, 2006.
  • Simon MS, Banerjee M, Crossley-May H, Vigneau FD, Noone AM, Schwartz K: “Racial Differences in Breast Cancer Survival in the Detroit Metropolitan Area.” Breast Cancer Research and Treatment, 97; 149-55, 2006.
  • Banerjee M, Noone AM. Tree-Based Methods for Survival Data. Statistical Advances in Biomedical Sciences: State of the Art and Future Directions (Eds. M. Segal, S. Datta, J. Fine). 265-285, 2008.
  • Movva S, Noone AM, Banerjee M, Patel D, Schwartz K, Yee CL, Simon MS: “Racial Differences in Cervical Cancer Survival in the Detroit Metropolitan Area.” Cancer, 112(6):1264-71, 2008.
  • Noone AM, Banerjee M. Machine Learning Methods for Cancer Diagnosis and Prognostication. Computational Methods in Biochemical Research (Eds. R. Khattree, D. Naik). 77-101, Chapman & Hall: Boca Raton, FL, 2008.
  • Wu RR, Lindenberg PA, Slack RS, Noone AM, Marshall JL, He AR (2009). Evaluation of Hypertension as a Marker of Bevacizumab Efficacy. Journal of Gastrointestinal Cancer, 40(3-4);101-8.
  • Liu MC, Shields PG, Warren RD, Cohen P, Wilkinson M, Ottaviano YL, Rao SB, Eng-Wong J, Seillier-Moiseiwitch F, Noone AM, Isaacs C (2009). Circulating tumor cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer. Journal of Clinical Oncology, 27(31);5153-9.
  • Yan B, Noone AM, Yee C, Banerjee M, Schwartz K, Simon MS (2009). Racial Differences in Colorectal Cancer Survival in the Detroit Metropolitan Area. Cancer, 115(16); 3791-800.
  • Aiello AE, Diez-Roux A, Noone AM, Ranjit N, Cushman M, Tsai MY, Szklo M (2009). Socioeconomic and Psychosocial Gradients in Cardiovascular Pathogen Burden and Immune Response: The Multi-Ethnic Study of Atherosclerosis. Brain, Behavior, and Immunity, 23(5); 663-71.
  • Broustas CG, Ross JS, Yang Q, Sheehan CE, Riggins RB, Cavalli LR, Haddad BR, Seillier-Moiseiwitsch F, Noone AN, Kallakury BVS, Haffty BG, Clarke R, and Kasid UN. (2010) The Pro-apoptotic Molecule BLID Interacts with Bcl-XL, and its Downregulation in Breast Cancer Correlates with Poor Disease Free and Overall Survival.” Clin Can Res, 16(11):2939-48.
  • Ahmadi N, Goldman R, Seillier-Moiseiwitsch F, Noone AM, Kosti O, Davidson BJ. (2010) “Decreased Risk of Squamous Cell Carcinoma of the Head and Neck in Users of Non-steroidal Anti-inflammatory Drugs.” Intl J Otolaryngology, 424161.
  • Mandelblatt JS, Sheppard VB, Hurria A, Kimmick G, Isaacs C, Taylor K, Kornblith AB, Noone AM, Luta G, Tallarico M, Barry WT, Hunegs L, Zon R, Naughton M, Winer E, Hudis C, Edge SB, Cohen HJ, Muss H (2010) Breast Cancer Adjuvant Chemotherapy Decisions in Older Women: The Role of Patient Preference and Interactions with Physicians. J Clin Oncol, 28(19):3146-53.
  • Sen A, Banerjee M, Li Y, Noone AM (2010): “A Bayesian Approach to Competing Risks Analysis with Masked Cause of Death.” Stats in Med, 29(16): 1681-95.
  • Unger KR, Lominska CE, Deeken JF, Davidson BJ, Newkirk KA, Gagnon GJ, Noone AM, Slack RS, Harter KW (2010). Fractionated Stereotactic Radiosurgery for Reirradiation of Head and Neck Cancer.” Intl J Radiat Oncol Biol Phys, 77(5): 1411-9.
  • MacLaughlin BW, Wang D, Liu N, Noone AM, Harazduk N, Lumpkin M, Haramati A, Saunders P, Dutton M, Amri H (2010). “Stress Biomarkers in Medical Students Participating in a Mind Body Medicine Skills Program.” Evidence Based Complementary and Alternative Medicine, doi:10.1093/ecam/neq039.
  • Dyba M, Wang A, Noone AM, Goerlitz D, Shields P, Zheng Y-L, Chung FL: “Metabolism of isothiocyanates in individuals with positive and null GSTM1 and T1 genotypes after drinking watercress juice.” Clinical Nutrition, 29(6): 813-8, 2010.
  • Wycherly BJ, Berkowitz F, Noone AM, Kim HJ: “Computed Tomography and Otosclerosis: A Practical Method to Correlate the Sites Affected to Hearing Loss.” Ann Otol Rhinol Laryngol, 119:789-794, 2010.
  • Banerjee M, Ding Y, Noone AM: “Identifying Representative Trees in Random Forest for Survival Data.” Accepted to Stat Med, 2011.
  • Wallington SF, Luta G, Noone AM, Caicedo L, Lopez-Class M, Sheppard V, Spencer C, Mandelblatt J: “Assessing the awareness of and willingness to participate in cancer clinical trials among immigrant Latinos.” J Comm Health, Epub ahead of print, 2011.
  • Cavalli LR, Noone AM, Makambi KH, Rone JD, Kasid UN, Haddad BR: “Loss of the BLID Tumor Suppressor Gene in Early-Onset Breast Cancer.” Cytogenetic and Genome Research, 135(1):19-24, 2011.

  • Shi, HR, Fessler, JA: “Quadratic regularization design for fan beam transmission tomography.” Proc. SPIE 5747, Medical Imaging: Image Proc., pp. 2023-33, 2005.
  • Fessler, JA, Lee, S, Olafsson, VT, Shi, HR, Noll, DC: “Toeplitz-based iterative image reconstruction for MRI with correction for magnetic field inhomogeneity.” IEEE Trans. Sig. Proc., 53(9):3393-402, 2005.
  • Shi, HR, Fessler, JA: “Quadratic regularization design for 3d cylindrical PET.” Proc. IEEE Nuc. Sci. Symp. Med. Im. Conf, 4: 2301-5, 2005.
  • Shi, HR, Fessler, JA: “Quadratic regularization design for 3D axial CT.” Proc. IEEE Nuc. Sci. Symp. Med. Im. Conf., pp. 2834-6, 2006.
  • Shi HR, Fessler JA: “Quadratic regularization design for 2D CT.” IEEE Trans. Med.Imag., 28(5):645-56, 2009.

  • Kirkoriani Y, Siskind J, Marmur E. Perioperative Management of Anticoagulant Therapy during Cutaneous Surgery: 2005 Survey of Mohs Surgeons. Dermatologic Surgery, 33(10): 1189-97, 2007.
  • Galvez MP, Morland K, Raines C, Kobil J, Siskind J, Godbold J, Brenner B: “Race and Food Sore Availability in an Inner-City Neighborhood.” Public Health Nutr, 11(6): 624-31, 2008.

  • Frame B, Stuart L. Beal, Raymond Miller, Jeannette Barrett and Paula Burger, “Mixed effects modeling of weight change associated with placebo and pregabalin administration”, J Pharmacokinet Pharmacodyn, 2007, 34(6):753-70.
  • Frame B, Miller R, Hutmacher MM: “Joint modeling of dizziness, drowsiness, and dropout associated with pregabalin and placebo treatment of generalized anxiety disorder”, J Pharmacokinet Pharmacodyn, 2009, 36(6):565-84.

  • Lee IH, Roberts R, Shah RB, Wojno KJ, Wei JT, Sandler HM: “Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer.” Intl J Radiat Oncol, Biol, Phys, 68:1059-1064, 2007.
  • Profit J, McCormick MC, Escobar GJ, Richardson DK, Zheng Z, Coleman-Phox K, Roberts R, Zupancic JAF (2007) “Neonatal Intensive Care Unit Census Influences Discharge of Moderately preterm Infants.” Pediatrics 119: 314-319.
  • Soto DE, Andridge R, Pan CC, Williams S, Taylor J, Sandler HM: “Determining if pretreatment PSA doubling time predicts PSA trajectories after radiation therapy for localized prostate cancer.” Radiotherapy and Oncology, 90; 389-394, 2008.
  • Soto, DE, Andridge, R, Pan, CC, Williams, S, Taylor, JMG, Sandler, HM: “In Patients Experiencing Biochemical Failure after Radiation Therapy Pretreatment Risk Group and PSA Velocity Predict Differences in Overall Survival and Biochemical Failure Free Interval.” Intl J Radiat Oncol Biol Phys, 71:1295-1301, 2008.
  • Soto DE, Glaser S, Roberts RH, Schipper MJ, McLaughlin PW, Ray ME, Sandler HM, Pan CC (2008). Impact of common iliac nodal treatment on radiation outcomes in localized prostate cancer. Urology 71; 313-317.
  • Soto DE, Andridge RR, Taylor JMG, McLaughlin PW, Sandler HM, Pan CC: “Predicting biochemical failure and overall survival through intra-therapy PSA changes during definitive external beam radiation.” Intl J Radiat Oncol, Biol, Phys, 72; 1408-1415, 2008.
  • Taylor JMG, Ankerst DP, Andridge RR: “Validation of Biomarker-based Risk Prediction Models.” Clin Can Res, 14:5977-83, 2008.
  • Andridge RR, Little RJA (2009). The use of sample weights in hot deck imputation. Journal of Official Statistics 25; 21-36, NIHMS#299472.
  • Clark N, Dodge J, Houle C, Thomas L, Andridge R, Awad D, Payton J (2010) Asthma in 10 to 13 year olds: Challenges at a time of transition. Clinical Pediatrics; In press.
  • Andridge RR, Little RJA (2010). A Review of Hot Deck Imputation for Survey Nonresponse. International Statistical Review 78; 40-64, NIHMS#299474.
  • Clark N, Dodge J, Shah S, Thomas L, Andridge R, Awad D (2010). A Current Picture of Asthma Diagnosis, Severity, Control In A Low Income Minority Preteen Population. Journal of Asthma 47; 150-155.
  • Clark N, Shah S, Dodge J, Thomas L, Andridge R, Little R (2010). An evaluation of asthma interventions for preteen students. Journal of School Health 80; 80-87.
  • Andridge RR, Little RJA (2011) Proxy Pattern-Mixture Analysis for Survey Nonresponse. Journal of Official Statistics, in press.
  • Andridge RR (2011) “Quantifying the impact of fixed effects modeling of clusters in multiple imputation for cluster randomized trials.” Biometrical Journal, 53; 57-74, NIHMS#298223.
  • Fagundes CP, Glaser R, Johnson SL, Andridge RR, Yang EV, Di Gregorio MP, Chen M, Lambert DR, Jewell SD, Bechtel MA, Hearne DW, Herron JB, Kiecolt-Glaser JK (2011). Basal cell carcinoma: Stressful life events and the tumor environment. Arch Gen Psychiatry, Formally accepted.
  • Glaser R, Andridge RR, Yang EV, Arwa S, DiGregorio MP, Chen M, Johnson SL, DeRenne L, Lambert DR, Jewell SD, Bechtell MA, Hearne DW, Herron JB, Kiecolt-Glaser JK (2011). Immune markers associated with risk for subsequent basal cell carcinomas. PLoS ONE 6(9): e25160. doi:10.1371/journal.pone.0025160
  • Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Glaser R (2011).Omega-3 supplementation lowers in ammation and anxiety in medical students: A randomized controlled trial. Brain, Behavior, and Immunity, 25; 1725-1734.
  • Rhoda DA, Murray DM, Andridge RR, Pennell ML, Hade EM (2011). Studies with staggered starts: Multiple baseline designs and group-randomized trials. American Journal of Public Health 101; 2164-2169.

  • Shojaie A, Michailidis G (2009) “Analysis of Gene Sets Based on the Underlying Regulatory Network.” J Computational Biol, 16(3): 407-26.
  • Shojaie A, Michailidis G (2010) Network Enrichment Analysis in Complex Experiments, Stat App Genetics Mol Biology,9(1): Article22, 2010.
  • Shojaie A, Michailidis G (2010) Penalized Likelihood Methods for Estimation of Sparse High Dimensional DAGs, Biometrika, 97(3):519-538.
  • Shojaie A, Michailidis: “ Discovering graphical Granger causality using the truncating lasso penalty.” Bioinformatics, 26(18):i517-i523, 2010.
  • Putluri N, Shojaie A, Vasu V, Nalluri S, Vareed S, Putluri V, Vivekanandan-Giri A, Creighton C, Byun J, Pennathur S, Sana T, Fischer S, Michailidis G, Sreekumar A: “Metabolomic Profiling Reveals A Role for Androgen in Activating Amino Acid Metabolism and Methylation in Prostate Cancer Cells.” PLoS One, 2011, 6(7):e21417.
  • Putluri N, Shojaie A, Vasu V, Vareed S, Nalluri S, Putluri V, Tallman C, Butler C, Sana S, Fischer S, Sica G, Brat D, Shi H, Weizer A, Terris M, Shariat S, Michailidis G, Sreekumar A: “Metabolomic Profiling Reveals Potential Markers and Mechanism for Bladder Cancer Progression.” Cancer Research, In Press, 2011.
  • Basu S, Shojaie A, Michailidis G: “Estimating Regulatory Networks from Time Course Gene Expression Data via Adaptive Penalization.” Proceedings of NIPS Workshop on Machine Learning in Computational Biology, Accepted, 2011

  • Franzblau A, Kazerooni EA, Sen A, Goodsitt MM, Lee SY, Rosenman KD, Lockey JE, Meyer CA. Gillespie BW, Petsonk EL, Wang ML (2009). Comparison of digital radiographs with film gradiographs for the classification of pneumoconiosis. Acad Radiol. Jun;16(6):669-77
  • Brand RE, Greer JB, Zolotarevsky E, Brand R, Du H, Simeone D, Zisman A, Gorchow A, Lee SY, Roy HK, Anderson M (2009). Pancreatic cancer patients who smoke and drink are diagnosed at younger ages. Clin Gastroenterol Hepatol. Sep;7(9):1007-12
  • Sen A, Lee SY, Gillespie BW, Kazerooni EA, Goodsitt MM, Rosenman KD, Lockey JE, Meyer CA. Petsonk EL, Wang ML, Franzblau A (2010). Comparison of reliability of classification for pneumoconiosis of film and digital radiographs: a modeling approach. Acad Radiol. Apr;17(4):511-19
  • Gulati RM, Wever EM, Tsodikov A, Penson D, Inoue LY, Katcher J, Lee SY, Heijnsdijk EA, Draisma G, De Koning HJ, Etzioni R: “What if I don’t Treat my PSA-Detected Prostate Cancer? Answers from Three Natural History Models.” Cancer Epidemiology Biomarkers & Prevention, in press, 2011

  • Pujana MA, Han JJ, Starita LM, Stevens KN , Tewari M, Ahn JS , Rennert G, Moreno V, Assmann V, ElShamy WM, Rual JF, Rozek LS, Gelman RS, Gunsalus KC, Greenberg RA, Sobhian B, Bertin N, Venkatesan K, Ayivi-Guedehoussou N, Lázaro C, Nathanson KL, Weber BL, Cusick ME, Hill DE, Livingston DM, Gruber SB, Parvin JD, Vidal M, Network modeling links breast cancer susceptibility and centrosome dysfunction, Nature Genet, 39, 1338-1349, 2007.
  • Stevens KN, Hakonarson H, Kim C, Doevendans P, Koeleman BPC, Mital S, Raue J, Glessner J, Coles JG, Moreno V, Granger A, Gruber SB , Gruber PJ: “Common variation in ISL1 confers genetic susceptibility for human congenital heart disease.” PLoS One, 5(5): e10855, 2010.
  • Castellsagué E, González S, Guinó E, Stevens KN, Borràs E, Raymond VM, Lázaro C, Blanco I, Gruber SB, Capellá G: “Allele-specific expression of APC in adenomatous polyposis families.” Gastroenterology 139(2):439-47, 2010.
  • Segui N, Stevens KN, Guin E, Rozek LS, Moreno V, Capella G, Gruber SB, Valle L: “No differences in germline allele-specific expression of TGFBR1 between colorectal cancer patients and controls.” Br J Cancer, 104(4):735-40 2011.
  • Stevens KN, Wang X, Fredericksen Z, Pankratz VS, Vachon CM, Olson JE, Couch FJ: “Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer.” Breast Cancer Res Treat, 129(2):617-22, 2011.
  • Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, Olswold C, Fasching PA, Miron P, Eccles D, Carpenter JE, Godwin AK, Ambrosone C, Winqvist R, Brauch H on behalf of the GENICA consortium, Schmidt MK, Cox A, Cross S, Sawyer E, Hartmann A, Beckmann MW, Schulz-Wendtland R, Ekici AB, Tapper WJ, Gerty SM, Durcan L, Graham N, Hein R, Nickels S, Flesch-Janys D, Heinz J, Sinn HP, Konstantopoulou I, Fostira F, Pectasides D, Dimopoulos AM, Fountzilas G, Clarke CL, Balleine R, Olson JE, Fredericksen Z, Diasio RB, Pathak H, Ross E, Weaver J, Rüdiger T, Försti A, Dünnebier T, Ademuyiwa F, Kulkarni S, Pylkäs K, Jukkola-Vuorinen A, Ko YD, Van Limbergen E, Janssen H, Peto J, Fletcher O, Giles GG, Baglietto L, Verhoef S, Tomlinson I, Kosma VM, Beesley J, Greco D, Blomqvist C, Irwanto A, Liu J, Blows FM, Dawson SJ, Margolin S, Mannermaa A, Martin NG, Montgomery GW, Lambrechts D, dos Santos Silva I, Severi G, Hamann U, Pharoah P, Easton DF, Chang-Claude J, Yannoukakos D, Nevanlinna H, Wang X, Couch FJ: “Common breast cancer susceptibility loci are associated with triple negative breast cancer.” Cancer Research 71(19):6240-6249 2011.
  • Stevens KN, Garcia-Closas M, Fredericksen Z, Kosel M, Pankratz VS, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Van ’t Veer LJ, Tollenaar RAEM, Fasching PA, Beckmann MW, Hein A, Ekici AB, Johnson N, Peto J, dos Santos Silva I, Gibson L, Sawyer E, Tomlinson I, Kerin MJ, Chanock S, Lissowska J, Hunter DJ, Hoover RN, Thomas GD, Milne RL, Arias Pérez JI, González-Neira A, Benítez J, Burwinkel B, Meindl A, Schmutzler RK, Bartrar CR, Hamann U, Ko YD, Brüning T, the GENICA Network, Chang-Claude J, Hein R, Wang-Gohrke S, Dörk T, Schürmann P, Bremer M, Hillemanns P, Bogdanova N, Zalutsky JV, Rogov YI, Antonenkova N, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen J, Chenevix-Trench G, Chen X, kConFab Investigators, Australian Ovarian Cancer Study Group, Peterlongo P, Bonanni B, Bernard L, Manoukian S, Wang X, Cerhan J, Vachon CM, Olson JE, Giles GG, Baglietto L, McLean CA, Severi G, John EM, Miron A, Winqvist R, Pylkäs R, Jukkola-Vuorinen A, Grip M, Andrulis I, Knight JA, Glendon G, Mulligan AM, Cox A, Brock IW, Elliott G, Cross SS, Pharoah PP, Dunning AM, Pooley KA, Humphreys MK, Wang J, Kang D, Yoo KY, Noh DY, Sangrajrang S, Gabrieau V, Brennan P, McKay J, Anton-Culver H, Ziogas A, Couch FJ, Easton DF: “Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) oncogene and breast cancer risk.” Br J Cancer 2011 Oct 27 [Epub ahead of print].
  • Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa F, Ahmed S, Ambrosone CB, Baglietto L, Balleine R, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Blot WJ, Brauch H, Buring JE, Carey LA, Carpenter JE, Chang-Claude J, Chanock SJ, Chasman DI, Clarke CL, Cox A, Cross SS, Deming SL, Diasio RB, Dimopoulos AM, Driver WR, Dünnebier T, Durcan L, Eccles D, Edlund CK, Ekici AB, Fasching PA, Feigelson HS, Flesch-Janys D, Fostira F, Försti A, Fountzilas G, Gerty SM, The GENICA Consortium, Giles GG, Godwin AK, Goodfellow P, Graham N, Greco D, Hamann U, Hankinson SE, Hartmann A, Hein R, Heinz J, Holbrook A, Hoover RN, Hu JJ, Hunter DJ, Ingles SA, Irwanto A, Ivanovich J, John EM, Johnson N, Jukkola-Vuorinen A, Kaaks R, Ko YD, Kolonel LN, Konstantopoulou I, Kosma VM, Kulkarni S, Lambrechts D, Lee AM, Le Marchand L, Lesnick T, Liu J, Lindstrom S, Mannermaa A, Margolin S, Martin NG, Miron P, Montgomery GW, Nevanlinna H, Nickels S, Nyante S, Olswold C, Palmer J, Pathak H, Pectasides D, Perou CM, Peto J, Pharoah P, Pooler L, Press MF, Pylkäs K, Rebbeck TR, Rodriguez-Gil JL, Rosenberg L, Ross E, Rüdiger T, dos Santos Silva I, Sawyer E, Schmidt MK, Schulz-Wendtland R, Schumacher F, Severi G, Sheng X, Signorello LB, Sinn HP, Stevens KN, Southey MC, Tapper WJ, Tomlinson I, Hogervorst FBL, Wauters E, Weaver J, Wildiers H, Winqvist R, Van Den Berg D, Wan P, Xia LY, Yannoukakos D, Zheng W, Ziegler RG, Siddiq A, Slager SL, Stram DO, Easton DF, Kraft P, Henderson BE, Couch FJ: “A susceptibility locus for estrogen receptor negative breast cancer subtypes at 5p15 (TERT).” Nat Genet 2011 Oct 30 Epub ahead of print]

  • King CA, Kerr DCR, Passarelli MN, Foster CE, Merchant CR. One-year follow-up of suicidal adolescents: Parent history of mental health problems and time to post-hospitalization attempt. J Youth and Adolescence, 2010; 39(3): 219-232.
  • Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Bersch AJ, Passarelli MN, Holick CN, Titus-Ernstoff L, Egan KM, Holmes MD, Willett WC: “Post-diagnosis dietary factors and survival after invasive breast cancer.” Breast Cancer Res Treat. 2011 Jan 1. Epub ahead of print
  • Coghill AE, Newcomb PA, Chia VM, Zheng Y, Wernli KJ, Passarelli MN, Potter JD: “Pre-diagnostic NSAID use but not hormone therapy use is associated with survival after a diagnosis of colorectal cancer in women.” Br J Cancer, 2011, 104(5):763-8.
  • Soto DE, Passarelli MN, Daignault S, Sandler HM: “Concurrent androgen deprivation therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk patients.” Int J Radiat Oncol Biol Phys 2011 May 5. (Epub ahead of print)
  • Passarelli MN, Coghill AE, Hutter CM, Zheng Y, Makar KW, Potter JD, Newcomb PA: “Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: A population-based study of postmenopausal women.” Genes Chromosomes Cancer. 2011 Nov;50(11):875-86.
  • Adams SV, Passarelli MN, Newcomb PA” “Cadmium exposure and cancer mortality in the third National Health and Nutrition Examination Survey cohort.” Occup Environ Med. 2011 (In Press)

  • Zhang J, Lee J, Urba S, Foster J, Worden F. A phase II trial evaluating weekly docetaxel and capecitabine in patients with metastatic or advanced, locally recurrent head and neck cancers. Cancer Invest, 28(9):910-916, 2010, PMID:20590443.
  • Foster, JC, Taylor, JMG, and Ruberg, SJ. Subgroup identification from randomized clinical trial data. Stats in Med, 30(24):2867-2880, 2011, PMCID:PMC3880775.
  • Foster JC, Taylor JMG, Nan B. Variable selection in monotone single-index models via the adaptive LASSO. Stat Med, 32(22):3944-3954, 2013, PMCID:PMC3773259
  • Mason H, DeRubeis MB, Foster JC, Taylor JMG, Worden FP. Outcomes evaluation of a weekly nurse practitioner-managed symptom management clinic for patients with head and neck cancer treated with chemoradiotherapy. Oncol Nurs Forum, 40(6):581-586, 2013, PMCID:PMC4764379.
  • Waterman JM, Nadeem E, Paczkowski E, Foster JC, Lavner JA, Belin T, Miranda J. Pre-placement risk and longitudinal cognitive development for children adopted from foster care. Child Welfare, 92(4):9-30, 2013, PMCID:PMC4772770.
  • Foster JC, Taylor JMG, Kaciroti N, Nan B. Simple subgroup approximations to optimal treatment regimes from randomized clinical trial data. Biostatistics, 16(2):368-382, 2015, PMCID:PMC5006409.
  • Taylor JMG, Cheng W, Foster JC. Reader reaction to a robust method for estimating optimal treatment regimes by Zhang et al. (2012). Biometrics, 71(1):267-271, 2015, PMCID:PMC4768908.
  • Foster JC, Nan B, Shen L, Kaciroti N, Taylor JMG. Permutaton testing for treatment-covariate interactions and subgroup identification. Statistics in Bioscience, 8(1):77-98, 2016, PMCID:PMC5010868.

  • Sanchez BN, Raghunathan TE, Diez Roux AV, Zhu Y, Lee O (2008) Combining data from primary and ancillary surveys to assess the association between neighborhood-level characteristics and health outcomes: the Multi-Ethnic Study of Artherosclerosis. Statistics in Medicine. November;27(27):5745-4763
  • Chen G, Kim S, Taylor JMG, Wang Z, Lee O, Ramnath N, Reddy RM, Lin J, Chang AC, Orringer MB, Beer DG: “Development and Validation of a qRT-PCR Classifier for Lung Cancer Prognosis.” Journal of Thoracic Oncology, in press, 2011.
  • Lee O, Braun TM: “Permutation tests for random effects in linear mixed models.” Biometrics, 68(2) 486-93, 2012
  • Chapman CH, Nazem-Zadeh M, Lee OE, Schipper MJ, Tsien Cl, Lawrence TS, Cao Y: "Regional Variation in Brain White Matter Diffusion Index Changes following Chemoradiotherapy: A Prospective Study Using Tract-Based Spatial Statistics." PLoS One, 8(3): e57768, 2013
  • Lao C, Friedman J, Tsien Cl, Normolle DP, Chapman C, Cao Y, Lee OE, Schipper M, VanPoznak C, Hamstra D, Lawrence T, Hayman J and Redman B: "Concurrent whole brain radiotherapy and bortezomib for brain metastasis." Radiation Oncology 2013; 8(1): 204, PMC3765365.
  • Liu E, Stenmark M, Schipper MJ, Balter JM, Kessler ML, Caoili EM, Lee OE, Ben-Josef E, Lawrence TS and Feng M: "Stereotactic Body Radiation Therapy for Primary and Metastatic Liver Tumors." Transl Oncol. 2013; 6(4): 442-446.
  • Hunter KU, Lee OE, Lyden TH, Haxer MJ, Feng FY, Schipper MJ, Worden F, Prince ME, McLean MA, Wolf GT, Bradford CR, Chepeha DA and Eisbruch A. Aspiration pneumonia after Chemo-lMRT of oropharyngeal carcinoma and its clinical and dysphagia-related predictors. Head and Neck, 36:120-125, 2014, PMCID:PMC4144677.
  • Rischin D, Spigel DR, Adkins D, Wein R, Arnold S, Singhal N, Lee O, Murugappan S. PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Head Neck, Suppl 1:E1756-1761, 2016. PMID:26681429.
  • Wilson RH, Chandra M, Scheiman JM, Lee SY, Lee OE, McKenna BH, Simeone DM, Taylor JM, Mycek MA. Tissue classification using optical spectoscopy accurately differentiates cancer and chronic pancreatitis. Pancreas, 46(2):244-251, 2017, PMCID:PMC5235923.

  • Kennedy EH, Taylor JMG, Schaubel DE, Williams SG: “The effect of salvage therapy on survival in a longitudinal study with treatment by indication.” Stats in Med, 29(25): 2569-2580, 2011, PMC2962719.
  • Fakih MG, Watson SR, Greene MT, Kennedy EH, Olmsted R, Krein SL, Saint S: “Promoting patient safety by reducing inappropriate urinary catheter use: a statewide effort in Michigan.” Arch Int. Med, (to appear)
  • Fakih MG, Greene MT, Kennedy EH, Meddings JA, Krein SL, Olmsted R, Saint S: “Introducing a population-based outcome measure to evaluate the effect of interventions to reduce catheter-associated urinary tract infection.” Am J Infect Control, in press, 2011.

  • Shuman AG, Yang Y, Taylor JM, Prince ME. End-of-life care among head and neck cancer patients. Otolaryngol Head Neck Surg, 144(4), 2011, PMCID:PMC3879721.
  • Yang Y, Little R. A Comparison of doubly robust estimators of the mean missing data. Journal of Statistical Computation and Simulation, 85(16):3383-3403, 2015.
  • Chen Q, Elliott MR, Haziza D, Yang Y, Ghosh M, Little RJA, Sedransk J, Thompson M. Approaches to improving survey-weighted estimates. Statistical Science, 32(2): 227-248, 2017.

  • Shuman AG, Entezamil P, Chernin AS, Wallace NE, Taylor JMG, Hogikyan NDDemographics and efficacy of head and neck cancer screening, Otolaryngology - Head and Neck Surgery, 2010, 143(3):353-60, PMID: 20723771
  • Conlon A, Taylor JMG, Sargent D, Yothers G: “Using Cure Models and Multiple Imputation to Utilize Recurrence as an Auxiliary Variable for Overall Survival.” Clin Trials; J Society for Clin Trials, 8(5): 581-90, 2011, NIHMS #309264.
  • Hamstra DA, Daignault S, Conlon ASC, Dunn RL, Sandler HM, Hembroff AL, Zietman AL, Kaplan I, Ciezki J, Kuban D, Wei JT, Sanda MG, Michalski J, and the PROSTQA Consortium Study Group: "Multi-Institutional Prospective Evaluation of Bowel Quality of Life After Prostate External Beam Radiation Therapy Identifies Patient and Treatment Factors Associated with Patient Reported Outcomes: The PROSTQA Experience". Intl J Radiat Oncol Biol Physics, 86(3):546-53, 2013
  • Sabel MS, Terjimanian M, Conlon ASC, Griffith KA, Morris AM, Mulholland MW, Englesbe MJ, Holcombe S, Wang SC: "Analytic Morphometric Assessment of Patients Undergoing Colectomy for Colon Cancer." J Surg Oncol, 108:169-175, 2013
  • Conlon ASC, Taylor JMG, Elliott MR: "Surrogacy Assessment Using Principal Stratification When Surrogate and Outcome Measures are Multivariate Normal." Biostatistics. 15(2):266-83, 2014
  • Conlon ASC, Taylor JMG, Sargent DJ: "Multi-State Models for Colon Cancer Recurrence and Death with a Cured Fraction." Stat Med, 33(10):1750-66, 2014
  • Stenmark MH, Conlon ASC, Johnson S, Daignault S, Litzenberg D, Marsh R, Ritter T, Vance S, Kazzi N, Feng F, Sandler H, Sanda MG, Hamstra DA: "Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer." Radiat Oncol, 110(2):291-7, 2014
  • Conlon ASC, Taylor JMG, Sargent DJ, Yothers G: "Improving Efficiency in Clinical Trials Using Auxiliary Information; Application of a Multi-State Cure Model." Biometrics, 71(2):460-8, 2015
  • Elliott M, Conlon ASC, Li Y, Kaciroti N, Taylor JMG: "Surrogacy Marker Paradox Measures in Meta-Analytic Settings". Biostatistics, 16(2):400-12, 2015
  • Taylor JMG, Conlon ASC, Elliott MR: "Surrogacy Assessment Using Principal Stratification with multivariate normal and Gaussian Copula Models." Clinical Trials, 12(4):317-22, 2015

  • Levy H, Seydafkan S, Rice JD, Easley KA, Tangpricha V: Comparative efficacy of vertebroplasty, kyphoplasty, and medical therapy for vertebral fractures on survival and prevention of recurrent fractures". Endocrine Practice 18, 499-507, 2012
  • Sabel MS, Rice JD, Griffith KA, Lowe L, Wong SL, Chang AE, Johnson TM, Taylor JMG: “Validation of Statistical Predictive Models Meant to Select Melanoma Patients for Sentinel Lymph Node Biopsy.” Annals of Surgical Oncology, 19(1:297-93, 2012.
  • Li S, Mukherjee B, Taylor JMG, Rice KM, Wen X, Rice JD, Stringham HM, Boehnke M: "The role of environmental heterogeneity in meta-analysis of gene environment interactions with quantitative traits". Genetic Epidemiology 38, 416-429, 2014
  • Rice JD, Taylor JMG: “Locally Weighted Score Estimation for Quantile Classification in Binary Regression Models” Statistics in Bioscience, in press, 2016
  • Estes JP, Rice JD, Li S, Stringham HM, Boehnke M, Mukherjee B. Meta-analysis of gene-environment interaction exploiting gene-environment independence across multiple case-control studies. Stat Med, 36(24):3895-3909, 2017, PMCID:PMC5624850.
  • Rice JD, Tsodikov A. Semiparametric profile likelihood estimation for continuous outcomes with excess zeros in a random-threshold damage-resistance model. Stat Med, 36(12):1924-1935. 2017, PMCID:PMC5530377.
  • Rice JD, Tsodikov A. Semiparametric time-to-event modeling in the presence of a latent progression event. Biometrics, 73(2):463-472, 2017, PMCID:PMC5325816.

  • Roca H, Craig MJ, Ying C, Varsos ZS, Czarnieski P, Alva AS, Hernandez J, Fuller D, Daignault­ Newton S, Healy PN, Pienta KJ. IL-4 induces proliferation in prostate cancer PC3 cells under nutrient-depletion stress through the activation of the JNK-pathway and surviving up-regulation. J Cell Biochem. 113(5): 1569-80, 2012, PMC3337359.
  • Jorns, J, Visscher D, Sabel M, Breslin T, Daignault-Newton S, Healy PN, Myers J, Wu A. lntraoperative frozen section analysis of margins in breast conserving surgeries significantly decreases re-operative rates: one year experience at an outpatient surgery center Amer J Clin Path, 138(5):657-69, 2012
  • Arps DP, Healy PN, Zhao L, Kleer CG and Pang JC:" Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast." Breast Cancer Res Treat, 138(3):719-26, 2013
  • Jorns JM, Healy PN, Zhao L: " Review of Estrogen Receptor, Progesterone Receptor, and HER-2/neu lmmunohistochemistry Impacts on Treatment for a Small Subset of Breast Cancer Patients Transferring." Arch Pathol Lab Med137(11):1660-3, 2013
  • Roca H, Hernandez J, Weidner S, McEachin RC, Fuller D, Sud S, Schumann T, Wilkinson JE, Zaslavsky A, Li H, Maher CA, Daignault-Newton, Healy PN, Pienta KJ: "Transcription Factors OVOL 1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer." PloS One, 8(10): e76773, 2013
  • O'Malley M, Healy PN, Daignault S, Ramnath N: "Cigarette Smoking and Gemcitabine-lnduced Neutropenia in Advanced Solid tumors." Oncology , 85(4) :216-22, 2013.
  • Jorns JM, Thomas DG, Healy PN, Daignault S, Vickery TL, Snider JE, Mardis ER, Davies SR, Ellis MJ, Visscher DW. Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma. Arch Pathol Lab Med, 138(11):1507-13, 2014, PMCID:PMC4327939

  • Boonstra PS, Gruber SB, Raymond VM, Huang SC, Timshel S, Nilbert M and Mukherjee B. A review of statistical methods for testing genetic anticipation: Looking for an answer in Lynch syndrome. Genetic Epidemiology, 34(7)756-768, 2010, PMCID:PMC3894615
  • Boonstra PS, Mukherjee B, Taylor JMG, Nilbert M, Moreno V and Gruber SB. Bayesian modeling for genetic anticipation in presence of mutational heterogeneity: A case-study in hereditary non-polyposis colorectal cancer (Lynch syndrome). Biometrics, 67(4):1627-1637, 2011, PMCID:PMC3176998.
  • Boonstra PS, Mukherjee B, Taylor JMG. Bayesian shrinkage methods for partially observed data with many predictors. Ann Appl Stat, 7(4):2272-2292, 2013, PMCID:PMC3891514.
  • Boonstra PS, Taylor JMG and Mukherjee B. Incorporating auxiliary information for improved prediction in high dimensional datasets: An ensemble of shrinkage approaches. Biostatistics, 14(2):259-272, 2013, PMCID:PMC3590922.
  • Boonstra PS, Bondarenko I, Park SK, Vokonas PS and Mukherjee B. Propensity score-based diagnostics for categorical response regression models. Statistics in Medicine 33(3):455-469, 2014, PMCID:PMC3911784.
  • Stenzel SL, Ahn J, Boonstra PS, Gruber SB, and Mukherjee B. The impact of exposure-biased sampling designs on detection of gene-environment interactions in case-control studies with potential exposure misclassification. European Journal of Epidemiology 30(5):413-423, 2015, PMCID:PMC4256150.
  • Boonstra PS, Mukherjee B, Taylor JMG. A small-sample choice of the tuning parameter in ridge regression. Stat Sin, 25(3):1185-1206, 2015, PMC:PMC4790465.
  • Boonstra PS, Shen J, Taylor J, Braun TM2, Griffith KA, Daignault S, Kalemkerian GP, Lawrence TS, Schipper MJ. A statistical evaluation of dose expansion cohorts in phase I clinical trials. J Natl Cancer Inst, 107(3). pii: dju429, 2015, PMCID:PMC4565529.
  • Boonstra PS, Taylor JMG, Mukherjee B. Adaptive shrinkage via the hyperpenalized EM algorithm. Stat Biosci, 7(2):417-431, 2015, PMCID:PMC4728141.
  • Stenzel SL, Ahn J, Boonstra PS, Gruber SB, and Mukherjee B. The impact of exposure-biased sampling designs on detection of gene-environment interactions in case-control studies with potential exposure misclassification. Eur J Epidemiol, 30(5):413-423, 2015, PMCID:PMC4256150.
  • Boonstra PS, Mukherjee B, Gruber SB, Ahn J, Schmit SL, and Chatterjee N. Tests for gene-environment interactions and joint effects with exposure misclassification. Am J Epidemiol, 83(3):237-247, 2016, PMCID:PMC4724093.
  • Boonstra PS, Taylor JMG and Mukherjee B. Increasing efficiency for estimating treatment-biomarker interactions with historical data. Stat Methods Med Res, 25(6):2959-2971, 2016, PMCID:PMC5450810.
  • Boonstra PS, Taylor JM, Smolska-Ciszewska B, Behrendt K, Dworzecki T, Gawkowska-Suwinska M, Bialas B, Suwinski R. Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boost. Br J Radiol, 89(1061):20150957, 2016, PMCID:PMC4985475.

  • Taylor JMG, Cheng W, Foster JC. Reader reaction to a robust method for estimating optimal treatment regimes by zhang et al. Biometrics, 71(1):267-271, 2015, PMCID:PMC4768908.
  • Cheng W, Taylor JMG, Mukherjee B, Vokonas P, Park SK. Improving estimation in linear regression incorporating external information from an established reduced model. Stat Med, 37(9):1515-1530, 2018, PMCID:PMC5889759.
  • Cheng W, Taylor JMG, Gu T, Tomlins SA, Mukherjee B. informing a risk prediction model for binary outcomes with external coefficient information. Journal of the Royal Statistical Society Series C, 68(1):121-139, 2019, PMCID:PMC6519970.
  • Gu T, Taylor JMG, Cheng W, Mukherjee B. Synthetic data method to incorporate external information into a current study. Canadian Journal of Statistics, 47(4):580-603, 2019, PMCID:PMC7410329.

  • Haymart MR, Muenz DG, Stewart AK, Griggs JJ, Banerjee M. Disease Severity and Radioactive Iodine Use for Thyroid Cancer. J Clin Endocrin Metab, 98(2):678-686, 2013, PMCID:PMC3565122.
  • Banerjee M, Muenz DG, Chang JT, Papaleontiou M, Haymart MR. Tree-based model for thyroid cancer prognostication. J Clin Endocrin & Metabol, 99(10):3737-3745, 2014, PMCID:PMC4184064.
  • Banerjee M, Muenz DG, Worden F, Wong SL, Haymart MR. Conditional survival in patients with thyroid cancer. Thyroid, 24(14):1784-1789, 2014, PMCID:PMC4267546.
  • Wiebal JL, Banerjee M, Muenz DG, Worden FP, Haymart MR. Trends in imaging after diagnosis of thyroid cancer. Cancer, 121(9):1387-1394, 2015, PMCID:PMC4409471.
  • Banerjee M, Lao CD, Wancata LM, Muenz DG, Haymart MR, Wong SL. Implications of age and conditional survival estimates for patients with melanoma. Melanoma Res, 26(1):77-82, 2016, PMCID:PMC5020374.
  • Wancata LM, Banerjee M, Muenz DG, Haymart MR, Wong SL. Conditional survival in advanced colorectal cancer and surgery. J Surg Res, 201(1):196-201, 2016, PMCID:PMC4744618.
  • Rosko AJ, Birkeland AC, Wilson KF, Muenz DG, Bellile E, Bradford CR, McHugh JB, Spector ME. Tumor biomarkers in spindle cell variant squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg, 155(1):106-112, 2016, PMCID:PMC4930715.
  • Meraj TS, Muenz DG, Glazer TA, Harvey RS, Spector ME, Hoff PT. Does drug-induced sleep endoscopy predict surgical success in transoral robotic multilevel surgery in obstructive sleep apnea? Laryngoscope, 127(4):971-976, 2017, PMID:27796047.
  • Muenz DG, Braun T, Taylor JMG. Modeling adverse event counts in phase I clinical trials of a cytotoxic agent. Clinical Trials, 15(4):386-397, 2018, PMCID:PMC6053332.
  • Scott GB, Brogly SB, Muenz D, Stek AM, Read JS. International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1025 Study Team: Missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus. Obstet Gynecol, 129(4):621-628, 2017, PMCID:PMC6122962.
  • Muenz DG, Taylor JMG, Braun T. Phase I-II trial design for biologic agents using conditional auto-regressive models for toxicity and efficacy. Journal of the Royal Statistical Society, 68(2)331-345, 2018, doi.org/10.1111/rssc.12314.

  • Manohar PM, Beesley LJ, Taylor JM, Hesseltine E, Haymart MR, Esfandiari NH, Hanauer DA, Worden FP. Retrospective study of sirolimus and cyclophosphamide in patients with advanced differentiated thyroid cancers. J Thyroid Disord Ther, 4(3):188, 2015, PMCID:PMC4831630.
  • Janz NK, Li Y, Beesley LJ, Wallner LP, Hamilton AS, Morrison RA, Hawley ST. Worry about recurrence in a multi-ethnic population of breast cancer survivors and their partners. Support Care Cancer, 24(11):4669-4678, 2016, PMCID:PMC7821383.
  • Beesley LJ, Bartlett JW, Wolf GT, Taylor JM. Multiple imputation of missing covariates for the Cox proportional hazards cure model. Stat Med, 35(26):4701-4717, 2016, PMCID:PMC5053880.
  • Sawyer ME, Evans MV, Wilson CA, Beesley LJ, Leon LS, Eklund CR, Croom EL, Pegram RA. Development of a human physiologically based pharmacokinetic (PBPK) model for dermal permeability for lindane. Toxicol Lett, 245:106-109, 2016, PMID:267994662.
  • Birkeland AC, Rosko AJ, Beesley L, Bellile E, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, Brenner JC, Spector ME. Preoperative tracheostomy is associated with poor disease-free survival in recurrent laryngeal cancer. Otolaryngol Head Neck Surg, 157(3):432-438, 2017, PMCID:PMC5593767.
  • Birkeland AC, Beesley L, Bellile E, Rosko AJ, Hoesli R, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, Brenner JC, Spector ME. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma. Head Neck, 39(12):2512-2518, 2017, PMCID:PMC5686454.
  • Schmitd LB, Beesley LJ, Russo N, Bellile EL, Inglehart RC, Liu M, Romanowicz G, Wolf GT, Taylor JMG, D'Silva NJ. Redefining perineural invasion: integration of biology with clinical outcome. Neoplasia, 20(7):657-667, 2018, PMCID:PMC6030236.
  • Hoban CW, Beesley LJ, Bellile EL, Sun Y, Spector ME, Wolf GT, Taylor JMG, Shuman AG. Individualized outcome prognostication for patients with laryngeal cancer. Cancer, 124(4):706-716, 2018, PMCID:PMC5800991.
  • Manohar PM, Beesley LJ, Bellile EL, Worden FP, Avram AM. Prognostic Value of FDG-PET/CT metabolic parameters in metastatic radioiodine-refractory differentiated thyroid cancer. Clin Nucl Med, 43(9):641-647, 2018, PMCID:PMC6076335.
  • Beesley LJ, Hawkins PG, Amlani L, Bellile EL, Casper KA, Chinn SB, Eisbruch A, Mierzwa ML, Spector ME, Wolf GT, Shuman AG, Taylor JMG. Individualized survival prediction for patients with oropharyngeal cancer in the human papillomavirus era. Cancer, 125(1): 68-78, 2019, PMCID:PMC6309492.
  • Beesley LJ, Morgan TM, Spratt DE, Singhal U, Feng FY, Furgal AC, Jackson WC, Daignault S, Taylor JMG. Individual and population comparisons of surgery and radiotherapy outcomes in prostate cancer using bayesian multistate models. JAMA Netw Open, 2(2):e187765, 2019, PMCID:PMC6484613.
  • Fritsche LG, Beesley LJ, VandeHaar P, Salvatore M, Zawistowski M, Gagliano SA, Das S, LeFaive J, Kaleba EO, Klumpner TT, Moser SE, Blanc VM, Brummett CM, Kheterpal S, Abecasis GR, Gruber SB, Mukherjee B: Exploring various polygenic risk scores for basal cell carcinoma, cutaneous squamous cell carcinoma and melanoma in the phenomes of the Michigan Genomics Initiative and the UK Biobank. PLOS Genetics, 15(6):e1008202, 2019, PMCID:PMC6592565.
  • Taylor JMG, Shuman AG, Beesley LJ. Individualized prognostic calculators in the precision oncolory era. Oncotarget, 10(4):415-416, 2019, PMCID:PMC6355181.
  • Beesley LJ, Taylor JMG. EM algorithms for fitting multistate cure models. Biostatistics, 20(3):416-432, 2019, PMCID:PMC6659172.

  • Wallner LP, Li Y, Furgal AKC, Friese CR, Hamilton AS, Ward KC, Jagsi R, Katz SJ, Hawley ST. Patient preferences for primary care provider roles in breast cancer survivorship care. Clin Oncol, 35(25):2942-2948, 2017, PMCID:PMC5575964.
  • Furgal AKC, Sen A, Taylor JMG: Review and comparison of computational approaches for joint longitudinal and time-to-event models. International Statistical Review, 87(2):393-418, 2019, PMCID:PMC7009936.
  • Beesley LJ, Morgan TM, Spratt DE, Singhal U, Feng FY, Furgal AC, Jackson WC, Daignault S, Taylor JMG. Individual and population comparisons of surgery and radiotherapy outcomes in prostate cancer using bayesian multistate models. JAMA Netw Open, 2(2):e187765, 2019, PMCID:PMC6484613.
  • Radhakrishnan A, Li Y, Furgal AKC, Hamilton AS, Ward KC, Jagsi R, Katz SJ, Hawley ST, Wallner LP. Provider involvement in care during initial cancer treatment and patient preferences for provider roles after initial treatment. Journal of Oncology Practice, 15(4):e328-e337, 2019, PMCID:PMC6550057.
  • Mahmoudi E, Kamdar N, Furgal A, Sen A, Zazove P, Bynum J. Potentially preventable hospitalizations among older adults: 2010-2014. Ann Fam Med, 18(6):511-519, 2020, PMCID:PMC7708283.
  • Arnedt JT, Conroy DA, Mooney A, Furgal A, Sen A, Eisenberg D. Telemedicine versus face-to-face delivery of cognitive behavioral therapy for insomnia: a randomized controlled noninferiority trial. Sleep, 44(1):zsaa136, 2021, PMID:32658298.

  • Hertz DL, Caram MV, Kidwell KM, Thibert JN, Gersch C, Seewald NJ, Smerage J, Rubenfire M, Henry NL, Cooney KA, Leja M, Griggs JJ, Rae JM. Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines. Pharmacogenomics, 17(3):231-40, 2016, PMCID:PMC5558515.
  • Kadakia KC, Snyder CF, Kidwell KM, Seewald NJ, Flockhart DA, Skaar TC, Desta Z, Rae JM, Otte JL, Carpenter JS, Storniolo AM, Hayes DF, Stearns V, Lynn Henry N. Patient-reported outcomes and early discontinuation in aromatase inhibitor-treated postmenopausal women with early stage breast cancer. Oncologist, 21(5):539-46, 2016, PMCID:PMC4861358.
  • Hertz DL, Kidwell KM, Seewald NJ, Gersch CL, Desta Z, Flockhart DA, Storniolo AM, Stearns V, Skaar TC, Hayes DF, Henry NL, Rae JM. Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer. Pharmacogenomics J, 17(6):521-527, 2017, PMCID:PMC532433.
  • Kadakia KC, Kidwell KM, Seewald NJ, Snyder CF, Storniolo AM, Otte JL, Flockhart DA, Hayes DF, Stearns V, Henry NL. Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors. Breast Cancer Res Treat, 164(2):411-419, 2017, PMCID:PMC5517133.
  • Meurer WJ, Seewald NJ, Kidwell K. Sequential multiple assignment randomized trials: an opportunity for improved design of stroke reperfusion trials. J Stroke Cerebrovasc Dis, 26(4):717-724, 2017, PMCID:PMC5362332.
  • Kidwell KM, Seewald NJ, Tran Q, Kasari C, Almirall D. Design and analysis considerations for comparing dynamic treatment regimens with binary outcomes from sequential multiple assignment randomized trials. Journal of Applied Statistics, 45(9): 1628-1651, 2017, PMCID: PMC6290190.

  • Hertz DL, Henry NL, Kidwell KM, Thomas D, Goddard A, Azzouz F, Speth KA, Li L, Banerjee M, Thibert JN, Kleer CG, Stearns V, Hayes DF, Skaar TC, Rae JM. ESR1 and PGR Polymorphisms Affect Estrogen and Progesterone Receptor Expression in Breast Tumors. Physiological Genomics, 48(9):688-698, 2016, PMCID:PMC5111879.
  • Bhave MA, Speth KA, Kidwell KM, Lyden A, Alsamarraie C, Murphy SL, Henry NL. Effect of aromatase inhibitor therapy on sleep and daytime activity patterns in early stage breast cancer. Clinical Breast Cancer, 18(2):68-174, 2017, PMCID:PMC6203440.
  • Hertz DL, Speth KA, Kidwell KM, Gersch CL, Desta Z, Storniolo AM, Stearns V, Skaar TC, Hayes DF, Henry NL, Rae JM. Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Research Treatment, 165(3):659-668, 2017, PMCID:PMC5709190.
  • Henry NL, Speth KA, Lintermans A, Kidwell KM, Carlson R, Hayes DF, Neven P. Associations between patient and anthropometric characteristics and aromatase inhibitor discontinuation. Clinical Breast Cancer, 17(5):350-355, 2017, PMCID:PMC5537010.
  • Kung TA, Kidwell KM, Speth KA, Pang JC, Jagsi R, Newman LA, Wilkins EG, Momoh AO. Radiation-Induced skin changes after postmastectomy radiation therapy: A pilot study on indicators for timing of delayed breast reconstruction. Journal of Reconstructive Microsurgery, 35(3):209-215, 2018, PMID:30231269.
  • Beeler WH, Speth KA, Broderick MT, Jairath NK, Ballouz D, Gharzai LA, Jackson WC, Kim MM., Owen D., Szerlip NJ, Paradis KC, Spratt DE. Local control and toxicity of multi-level spine stereotactic body radiosurgery. Neurosurgery, 86(2):E164-E172, 2019, PMID: 31541240.
  • Morishita M, Wang L, Speth K, Zhou N, Bard RL, Brook JR, Rajagopalan S, Brook RD. Acute cardiovascular effects of near-roadway exposures with and without N95-Respirators. American Journal of Hypertension, 32(11):1054-1065, 2019, PMCID:PMC7962899.
  • Billig JI, Speth KA, Nasser JS, Wang L, Chung KC. Assessment of surgeon variation in adherence to evidence-based recommendations for treatment of trigger finger. JAMA Network Open, 2(10):e1912960, 2019, PMCID:PMC6804023.
  • Speth K, Wang L. Restricted sub-tree learning to estimate an optimal dynamic-treatment regime using observational data. Stat Med, 40(26):5796-5812, 2021.
  • Speth K, Yoon AP, Wang L, Chung KC. Assessment of tree-based statistical learning to estimate optimal personalized treatment decisions rules for traumatic finger amputations. JAMA Open Network, 3(2):e1921626-e1921636, 2020.

  • van Die MD, Williams SG, Emery J, Bone KM, Taylor JM, Lusk E, Pirotta MV. A placebo-controlled double-blinded randomized pilot study of combination phytotherapy in biochemically recurrent prostate cancer. Prostate, 77(7):765-775, 2017, PMCID:PMC5444299
  • Qin A, Lusk E, Daignault-Newton S, Schneider B. Chemotherapy and Radiation Versus Chemotherapy Alone for Elderly Patients With N3 Stage IIIB NSCLC. Clin Lung Cancer, 20(4):e495-e503, 2019, PMCID:PMC6629485.

  • Gottschlich A, Nuntadusit T, Zarins KR, Hada M, Chooson N, Bilheem S, Navakanitworakul R, Nittayaboon K, Virani S, Rozek L, Sriplung H & Meza R. Barriers to cervical cancer screening and acceptability of HPV self-testing: a cross-sectional comparison between ethnic groups in Southern Thailand. BMJ Open, 9(11):e031957, 2019, PMCID:PMC6858097.
  • Murchland AR, Gottschlich A, Bevilacqua K, Pineda A, Sandoval-Ramírez BA, Alvarez CS, Ogilvie GS, Carey TE, Prince N, Dean M, Mendoza-Montano C, Rivera-Andrade A & Meza R. HPV self-sampling acceptability in rural and indigenous communities in Guatemala: a cross-sectional study. BMJ Open, 9:e029158, 2019, PMCID:PMC6830827.
  • Gottschlich A, Rivera-Andrade A, Bevilacqua K, Murchland AR, Isak E, Alvarez CS, Ogilvie G, Carey TE, Prince M, Dean M, Mendoza-Montano C, Meza R. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis. BMC Public Health, 20(1):1406, 2020, PMCID:PMC72493167.
  • Gottschlich A, Mus S, Monzon JC, Thrasher JF, Barnoya J. Cross-sectional study on the awareness, susceptibility and use of heated tobacco products among adolescents in Guatemala City, Guatemala. BMJ Open, 10(12):e039792, 2020, PMCID:PMC7737060.
  • Gottschlich A, van Niekerk D, Smith LW, Gondara L, Melnikow J, Cook DA, Lee M, Stuart G, Martin RE, Peacock S, Franco EL, Coldman A, Krajden M, Ogilvie G. Assessing 10-Year safety of a single negative HPV test for cervical cancer screening: Evidence from FOCAL-DECADE Cohort. Cancer Epidemiol Biomarkers Prev, 30(1):22-29, 2020, PMCID:PMC8284866.
  • Gottschlich A, Ochoa P, Rivera-Andrade A, Alcarez CS, Mendoza-Montano C, Camel C & Meza R. Barriers to cervical cancer screening in Guatemala: A quantitative analysis using data from the guatemala demographic and health surveys. International Journal of Public Health, 65(2):217-226, 2020, PMCID:PMC7049547.

  • East EG, Gast KM, Kuzon WM Jr, Roberts E, Zhao L, Jorns JM. Clinicopathological findings in female-to-male gender-affirming breast surgery. Histopathology,71(6):859-865, 2017, PMID: 28657118.
  • Muller KE, Roberts E, Zhao L, Jorns JM. Isolated atypical lobular hyperplasia diagnosed on breast biopsy: Low upgrade rate on subsequent excision with long-term follow-up. Arch Pathol Lab Med, 2018 Mar;142(3):391-395, 2017, PMID:29160721.
  • East E, Gabbeart M, Roberts E, Zhao L, Jorns J. A rapid triage protocol to optimize cold ischemic time for breast resection specimens. Annals of Diagnostic Pathology, 34:94-97, 2018, PMID:29661737.
  • Geer M, Roberts E, Shango M, Till B, Smith S, Abbas H, Hill B., Kaplan J, Barr PM, Caimi PF, Stephens DM, Lin E, Herrera AF, Rosenbaum E, Amengual K, Boonstra PS, Devata S, Wilcox RA, Kaminski M, and Phillips T. Multicentre retrospective study of intravascular large B‐cell lymphoma treated at academic institutions within the United States. British journal of haematology, 186(2):255-262, 2019, PMCID:PMC8989046.
  • Needham BL, Salerno S, Roberts E, Boss J, Allgood KL, Mukherjee B. Do black/white differences in telomere length depend on socioeconomic status? Biodemography Soc Biol, 65(4):287-312, 2019, PMCID:PMC7703670.
  • East E, Roberts E, Zhao L, Jorns J. Repeat biomarker status in breast resection specimens with controlled cold ischemic time.  American Journal of Clinical Pathology. 152(6):766-774, 2019, PMID:31338514.
  • Siontis BL, McHugh JB, Roberts E, Zhao L, Thomas DG, Owen D, Baker LH, Biermann JS, Schuetze SM, Chugh R. Differential outcomes and biologic markers of radiation-associated vs. sporadic osteosarcoma: A single-institution experience. Front Oncol, 9:1523, 2019, PMCID:PMC6987384.
  • Hanks JE, Kovatch KJ, Ali SA, Roberts E, Durham AB, Smith JD, Bradford CR, Malloy KM, Boonstra PS, McKean SA. Sentinel lymph node biopsy in head & neck melanoma: Long-term outcomes, prognostic value, & accuracy. Otolaryngology-Head and Neck Surgery, 162(4):520-529, 2020, PMCID:PMC8012010.
  • Sun Y, Patel A, SantaLucia J, Roberts E, Zhao L, Kaye K, Rao K, Bachman MA. Measurement of klebsiella intestinal colonization density to assess infection risk. mSphere. 6(3):e0050021, 2021, PMCID:PMC8265666.
  • Roberts E, Zhao L. A Bayesian mixture model for changepoint estimation using ordinal predictors. Int J Biostat. 2021 Apr 6. doi: 10.1515/ijb-2020-0151, 2021, PMID:33823087.
  • Roberts EK, Elliott MR, Taylor JMG/ Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm. Stat Med, 40(29), 6605-6618, 2021.
  • Roberts EK, Elliott MR, Taylor JMG. Solutions for surrogacy validation with longitudinal outcomes for a gene therapy. Biometrics. In Press.

  • Hu C, Tsodikov A. Semiparametric regression analysis for time-to-event marked endpoints in cancer studies. Biostatistics,5(3) 513-525, 2014, PMCID:PMC4102917.
  • Hu C, Tsodikov A. Joint modeling approach for semicompeting risks data with missing nonterminal event status. Lifetime Data Anal, 20(4)563-583, 2014, PMCID:PMC4101077.

  • Dess RT, Hartman HE, Aghdam N, Jackson WC, Soni PD, Abugharib AE, Suy S, Desai NB, Zumsteg ZS, Mehra R, Morgan TM, Feng FY, Hamstra DA, Schipper MJ, Collins SP, Spratt DE. Erectile function after stereotactic body radiotherapy for localized prostate cancer. BJU Int. 121(1):61-68, 2018, PMID:28710895.
  • Hartman H, Wang Y, Schroeder HW Jr, Cui X. Absorbance summation: A novel approach for analyzing high-throughput ELISA data in the absence of a standard. PLoS One, 13(6):e0198528, 2018, PMCID:PMC5993274.
  • Wahl DR, Kim MM, Aryal MP, Hartman H, Lawrence TS, Schipper MJ, Parmar HA, Cao Y. Combining perfusion and high B-value fiffusion MRI to inform prognosis and predict failure patterns in glioblastoma. Int J Radiat Oncol Biol Phys, 102(4):757-764, 2018, PMID:29980414.
  • Jackson WC, Silva J, Hartman HE, Dess RT, Kishan AU, Beeler WH, Gharzai LA, Jaworski EM, Mehra R, Hearn JWD, Morgan TM, Salami SS, Cooperberg MR, Mahal BA, Soni PD, Kaffenberger S, Nguyen PL, Desai N, Feng FY, Zumsteg ZS, and Spratt DE. Stereotactic body radiation therapy for localized prostate cancer: a systematic review and metaanalysis of over 6,000 patients treated on prospective studies. Internation Journal of Radiation Oncology Biology Physics, 104:778–789, 2019, PMCID:PMC6770993.
  • *Dess RT, *Hartman HE, *Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, Schaeffer, EM, Roach III M, Pisansky TM, Shipley WU, Freedland SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, and #Spratt DE. Association of black race with prostate cancer-specific and other-cause mortality. JAMA Oncology, 5(7):975-983, 2019, PMCID:PMC6547116.
  • Soni PD, Hartman HE, Dess RT, Abugharib A, Allen SG, Feng FY, Zeitman AL, Jagsi R, Schipper MJ, and #Spratt DE. Comparison of population-based observational studies with randomized trials in oncology. Journal of Clinical Oncology, 37(14):1209-1216, 2019, PMCID:PMC7186578.
  • Mendiratta-Lala M, Masch W, Shankar PR, Hartman HE, Davenport MS, Schipper MJ, Maurino C, Cuneo KC, Lawrence TS, and Owen D. Magnetic resonance imaging evaluation of hepatocellular carcinoma treated with stereotactic body radiation therapy: long term imaging follow-up. International Journal of Radiation Oncology Biology Physics, 37(14):1209-1216, 2019, PMCID:PMC6301102.
  • Hartman HE, Sun Y, Devasia T, Chase E, Jairath, NK, Dess RT, Jackson WC, Morris E, Li P, Hochstedler KA, Abbott M, Kidwell K, Walter V, Wang M, Wang X, Zaorsky N, Schipper MJ, and #Spratt DE. Integrated survival estimates from cancer treatment delay during the Covid-19 pandemic., JAMA Oncology, 6(12):1881-1889, 2020, PMCID:PMC7596687.
  • Nuccitelli R, McDaniel A, Connolly R, Zelickson B, Hartman H. Nano-Pulse stimulation induces changes in the intracellular organelles in rat liver tumors treated in Situ. Lasers Surg Med, 52(9):882-889, 2020, PMC:PMC7586959.
  • Jackson WC, Hartman HE, Dess RT, Birer SR, Soni PD, Hearn JWD, Reichert ZR, Kishan AU, Mahal BA, Zumsteg ZS, Efstathiou JA, Kaffenberger S, Morgan TM, Mehra R, Showalter TN, Krauss DA, Nguyen PL, Schipper MJ, Feng FY, Sandler HM, Hoskin PJ, Roach M 3rd, Spratt DE. Addition of androgen-deprivation therapy or brachytherapy boost to external beam radiotherapy for localized prostate cancer: a network meta-analysis of randomized trials. J Clin Oncol, 38(26):3024-3031, 2020, PMCID:PMC8265327.
  • Hartman HE, Jackson WC. Surrogate endpoints in localized prostate cancer. Cancer J, 26(1):48-52, 2020, PMID:31977385.
  • Ma TM, Romero T, Nickols NG, Rettig MB, Garraway IP, Roach M 3rd, Michalski JM, Pisansky TM, Lee WR, Jones CU, Rosenthal SA, Wang C, Hartman H, Nguyen PL, Feng FY, Boutros PC, Saigal C, Chamie K, Jackson WC, Morgan TM, Mehra R, Salami SS, Vince R, Schaeffer EM, Mahal BA, Dess RT, Steinberg ML, Elashoff D, Sandler HM, Spratt DE, Kishan AU. Comparison of response to definitive radiotherapy for localized prostate cancer in black and white men: A Meta-analysis. JAMA Netw Open, 1;4(12)e2139769, 2021, PMCID:PMC8717118.
  • Spratt DE, Malone S, Roy S, Grimes S, Eapen L, Morgan SC, Malone J, Craig J, Dess RT, Jackson WC, Hartman HE, Kishan AU, Mehra R, Kaffenberger S, Morgan TM, Reichert ZR, Alumkal JJ, Michalski J, Lee WR, Pisansky TM, Feng FY, Shipley W, Sandler HM, Schipper MJ, Roach M 3rd, Sun Y, Lawton CAF. Prostate Radiotherapy with Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis. .J Clin Oncol, 39(2):136-144, 2021 PMCID:PMC8189640.
  • Hartman H, Tamura RN, Schipper MJ, Kidwell KM. Design and analysis considerations for utilizing a mapping function in a small sample, sequential, multiple assignment, randomized trials with continuous outcomes. Stat Med, 40(2):312-326, 2021 PMCID:PMC9109654.
  • Jackson WC, Hartman HE, Gharzai LA, Maurino C, Karnak DM, Mendiratta-Lala M, Parikh ND, Mayo CS, Haken RKT, Schipper MJ, Cuneo KC, Lawrence TS. The Potential for Midtreatment Albumin-Bilirubin (ALBI) Score to Individualize Liver Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys, 111(1):127-134, 2021, PMID:33878421.

  • Chase E and Boonstra P . Accounting for established predictors with the multi-step elastic net. Stat Med, 38(23):4534-4544, 2019, PMCID:PMC6736688
  • Hartman H, Sun Y, Devasia T, Chase E, Jairath N, Dess R, Jackson W, Morris E, Li P, Hochstedler K, Abbott M, Kidwell K, Walter V, Wang M, Wang X, Zaorsky N, Schipper M, Spratt D. Integrated survival estimates for cancer treatment delay among adults with cancer during the coronavirus disease 2019 (COVID-19) Pandemic. JAMA Oncology, 6(12):1881-1889, 2020, PMCID:PMC7596687
  • Boonstra P, Braun T, Chase E. A modular framework for seamless oncology trials. Clinical Trials, 18(3):303-313, 2021, PMCID:PMC8382494
  • Ezell JM, Griswold D, Chase EC, Carver E. The blueprint of disaster: COVID-19, the Flint water crisis, and unequal ecological impacts. Lancet Planet Health, 5(5):e309-e315, 2021, PMID:33964240.
  • Ezell JM, Chase EC. A population-based assessment of physical symptoms and mental health outcomes among adults following the flint water crisis. J Urban Health, 98(5):642-653, 2021, PMCID:PMC8566686.
  • Chase E, Bryant K, Sun Y, Jackson WC, Spratt D, Dess RT, Schipper M. Development and validation of a life expectancy calculator for U.S. prostate cancer patients. BJU International, 130(4):496-506, 2022, PMCID:PMC9474626.

  • Fritsche L, Beesley L, VandeHaar P, Peng R, Salvatore M, Zawistowski M, Taliun S, LeFaive J, Kaleba E, Klumpner T, Moser S, Blanc V, Mukherjee B. Exploring various polygenic risk scores for skin cancer in the phenomes of the Michigan genomics initiative and the UK Biobank with a visual catalog: PRSWeb. Plos Genetics, 15(6):e1008202, 2019, PMCID:PMC6592565.
  • Fritsche LG, Patil S, Beesley LJ, VandeHaar P, Salvatore M, Ma Y, Peng RB, Taliun D, Zhou X, Mukherjee B. Cancer PRSweb: An online repository with polygenic risk scores for major cancer traits and their evaluation in two independent biobanks. Am J Hum Genet, 107(5):815-836, 2020, PMCID:PMC7675001.

  • Tosoian JJ, Feldman A, Abbott MR, Mehra R, Tiemeny P, Wolf JS, Stone S, Wu S, Daignault-Newton S, Taylor JMG, Wu C-L, Morgan TM. Biopsy cell cycle proliferation score predicts adverse surgical pathology in localized renal cell carcinoma Eur Urol, 78(5):657-660, 2020, PMID:32943262.
  •  Hartman HE, Sun Y, Devasia TP, Chase EC, Jairath NK, Dess RT, Jackson WC, Morris E, Li P, Hochstedler KA, Abbott MR, Kidwell KM, Walter V, Wang M, Wang X, Zaorsky NG, Schipper MJ, Spratt DE. Integrated survival estimates for cancer treatment delay among adults with cancer during the COVID-19 pandemic. JAMA Oncology, 6(12):1881-1889, 2020, PMCID:PMC7596687.

  • Meng X, Chang TS, Feng S, Lee M, Jaiswal S, Choi EY, Tran L. et al. Multi-modal imaging for uptake of peptide ligand specific for CD44 by hepatocellular carcinoma. Photoacoustics, 26:100355, 2022, PMCID:PMC9035732.
  • Tran L, He K, Wang D, Jiang H. A Cross-validation statistical framework for asymmetric data integration. Biometrics, 2022, doi: 10.1111/biom.13685, PMID:35524490.

  • Brown DL, Shafie-Khorassani F, Kim S, Chervin RD, Case E, Yadollahi A, Lisabeth LD. Do apneas and hypopneas best reflect risk for poor outcomes after stroke? Sleep Medicine, 63:14-17, 2019, PMCID:PMC6939631.
  • Lank RJ, Lisabeth LD, Levine DA, Zahuranec DB, Kerber KA, Shafie-Khorassani F, Case E, Zuniga BG, Cooper GM, Brown DL, Morgenstern LB. Ethnic differences in 90-day post-stroke medication adherence. Stroke, 50(6): 1519-1524, 2019, PMCID:PMC6597008.
  • Shafie-Khorassani F, Piper ME, Jorenby DE, Baker TB, Benowitz NL, Hayes-Birchler T, Meza R, Brouwer AF. The impact of demographics, dependence, and biomarkers on transitions in tobacco product use in a cohort of smokers and dual users. Accepted in Nicotine and Tobacco Research.  2022.
  • Schütz SG, Lisabeth LD, Shafie-Khorassani F, Case E, Sánchez BN, Chervin RD, Brown DL. Clinical phenotypes of obstructive sleep apnea after ischemic stroke: a cluster analysis. Sleep Medicine, 60:178-181, 2019, PMCID:PMC7424592.
  • Bailoor K, Shafie-Khorassani F, Lank RJ, Case E, Garcia NM, Lisabeth LD, Sánchez BN, Morgenstern LB, Zahuranec DB. Time trends in race-ethnic differences in do-not-resuscitate orders after stroke. Stroke, 50(7):1641-1647, 2019, PMCID:PMC6597008.
  • Brown DL, Shafie-Khorassani F, Kim S, Chervin RD, Case E, Morgenstern LB, Yadollahi A, Tower S, Lisabeth LD. Sleep-disordered breathing is associated with recurrent ischemic stroke. Stroke, 2019, 50(3):571-576, 2019, PMCID:PMC6389387.
  • Sozener CB, Lisabeth LD, Shafie-Khorassani F, Kim S, Zahuranec DB, Brown DL, Skolarus LE, Burke JF, Kerber, KA, Meurer WJ, Garcia N, Case E, Morgenstern LB. Trends in stroke recurrence in Mexican Americans and non-Hispanic whites. Stroke, 51(8):2428-2434, 2020, PMCID:PMC7387185.
  • Markovitz N, Morgenstern LB, Shafie-Khorassani F, Cornett BA , Kim S, Ortiz C, Lank RJ, Case E, Zahuranec DB. Family perceptions of quality of end-of-life care in stroke. Palliative Medicine Reports, 1(1):129-134, 2020, PMCID:PMC7446249.   
  • Lank RJ, Shafie-Khorassani F, Zhang X, Ortiz C, Kim S, Sánchez BN, Case E, Creutzfeldt CJ, Morgenstern LB, Zahuranec DB. Advance care planning and transitions to comfort measures after stroke. Journal of Palliative Medicine, 24(8):1191-1196, 2021, PMCID:PMC8309394.

  • Ma V, Su C, Hu M, Taylor J, Daignault-Newton S, Kellezi O, Dahl M, Shah M, Erickson S, Lora J, Hamasha R, Ali A, Yancey S, Kiros L, Balicki H, Winfield D, Green M, Alva A. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors. Urol Oncol, 39(7):437.e9, 2021, PMCID:PMC8286282.

  • Levy DT, Meza R, Yuan Z, Li Y, Cadham C, Sanchez-Romero LM, Travis N, Knoll M, Liber AC, Mistry R, Hirschtick JL, Fleischer NL, Skolnick S, Brouwer AF, Douglas C, Jeon J, Cook S, Warner KE. Public health impact of a US ban on menthol in cigarettes and cigars: a simulation study. Tobacco Control, doi: 10.1136/tobaccocontrol-2021-056604, 2021, PMCID: PMC9210349.
  • Levy DT, Sanchez-Romero LM, Travis N, Yuan Z, Li Y, Skolnick S, Jeon J, Tam J, Meza R. US Nicotine Product SimSmoke Simulation Model: The effect of vaping and tobacco control policies on smoking prevalence and smoking attributable deaths. International J Environmental Research and Public Health, 18(9):4876, 2021, PMCID:PMC8124578.